研究单位：[1]Ferring Pharmaceuticals[2]Beijing Obstetrics and Gynecology Hospital,Capital Medical University[3]Medical Center for Human Reproduction,Peking University Third Hospital[4]Peking University First Hospital[5]West China Second University Hospital of Sichuan University[6]Sun Yat-sen Memorial Hospital,Sun Yat-sen University[7]The Sixth Affiliated Hospital of Sun Yat-sen University[8]The Third Affiliated Hospital of Guangzhou Medical University[9]The First Affiliated Hospital of An'hui Medical University[10]Jiangsu Province Hospital[11]ShengJing Hospital of China Medical University[12]Peking University Shenzhen Hospital[13]Tianjin Central Hospital of Gynaecology and Obstetrics[14]Tianjin Medical University General Hospital[15]Renmin Hospital of Wuhan University[16]Tongji Hospital,Tongji Medical College,Huazhong University of Science & Technology
研究目的：
To demonstrate non-inferiority of FE 999049 compared with GONAL-F with respect to ongoing pregnancy rate in women undergoing controlled ovarian stimulation.
